Validity of HAS-BLED Score in Prediction of Major Bleeding Risk in Patients with Atrial Fibrillation Taking Warfarin and Dabigatran

被引：0
|
作者：
Nunez, Arismendy S. [1 ]
Htun, Wah Wah [1 ]
Patel, Kaushink [1 ]
Kim, John [1 ]
Al-Awwad, Omar [1 ]
Fernaine, George [1 ]
机构：
[1] Lutheran Med Cntr, Brooklyn, NY USA
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Anticoagulants;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15722
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
    Adeboyeje, Gboyega
    Sylwestrzak, Gosia
    Barron, John J.
    White, Jeff
    Rosenberg, Alan
    Abarca, Jacob
    Crawford, Geoffrey
    Redberg, Rita
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (09): : 968 - 978
  • [42] The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion
    Garcia-Fernandez, Amaya
    Marin, Francisco
    Roldan, Vanessa
    Galcera-Jornet, Emilio
    Gabriel Martinez-Martinez, Juan
    Valdes, Mariano
    Sogorb, Francisco
    Lip, Gregory Y. H.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 217 : 42 - 48
  • [43] Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial
    Senoo, Keitaro
    Lip, Gregory Y. H.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 379 - 382
  • [44] Predictive value of the HAS-BLED score for major bleeding in patients with venous thromboembolism during anticoagulant treatment
    Kooiman, J.
    Van Hagen, N.
    del Sol, Iglesias A.
    Planken, E.
    Lip, G. Y. H.
    Van Der Meer, F. J. M.
    Cannegieter, S. C.
    Huisman, M., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 441 - 441
  • [45] Comparison of the HAS-BLED, ATRIA and HEMORR2HAGES scores to the CHADS2 score for bleeding risk in atrial fibrillation patients on warfarin therapy: the MAQI2 experience
    Barnes, D.
    Gu, X.
    Haymart, B.
    Kline-Rogers, E.
    Almany, S.
    Kozlowski, J.
    Besley, D.
    Krol, G. D.
    Froehlich, J. B.
    Kaatz, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 3 - 3
  • [46] THE HAS-BLED SCORE AS A PREDICTOR FOR MORTALITY IN DIALYSIS PATIENTS WITH ATRIAL FIBRILLATION: CHALLENGES AND OPPORTUNITY FOR FUTURE STUDY
    Wong, J.
    Waller, J.
    Diamond, M.
    Bushik, S.
    Sayed, A.
    Kheda, M. F.
    Nahman, N. S.
    Sorrentino, R.
    Maddox, W.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 684 - 684
  • [47] Improvement of HAS-BLED bleeding score predictive capability by changing the definition of renal dysfunction in Japanese atrial fibrillation patients on anticoagulation therapy
    Suzuki, Makoto
    Matsue, Yuya
    Nakamura, Rena
    Matsumura, Akihiko
    Hashimoto, Yuji
    [J]. JOURNAL OF CARDIOLOGY, 2014, 64 (5-6) : 482 - 487
  • [48] Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis
    Wang, Cen
    Yu, Ye
    Zhu, Wengen
    Yu, Jianhua
    Lip, Gregory Y. H.
    Hong, Kui
    [J]. ONCOTARGET, 2017, 8 (65) : 109703 - 109711
  • [49] Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillation
    Lau, Yee C.
    Lip, Gregory Y. H.
    Gallego, Pilar
    [J]. HYPERTENSION RESEARCH, 2014, 37 (07) : 699 - 700
  • [50] EXTERNAL VALIDATION OF THE ORBIT BLEEDING AND THE HAS-BLED SCORE IN ATRIAL FIBRILLATION PATIENTS USING DIRECT ORAL ANTICOAGULANTS: SUBANALYSIS OF THE DIRECT REGISTRY
    Mori, Naoki
    Sotomi, Yohei
    Hirata, Akio
    Hirayama, Atsushi
    Higuchi, Yoshiharu
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 370 - 370
12345